Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiharu Mizoguchi
Observed names:
M. Chiharu,
Mizoguchi, Chiharu
Institution:
National Cancer Center Hospital
Observed institutions:
Oita University,
National Cancer Centre Japan,
National Cancer Center Hospital,
National Cancer Center Hospital
ORCID:
0000-0003-2801-6664
Observed ORCID:
0000-0003-2801-6664
OpenAlex ID:
A5029096671
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
2023
·
Sho Watanabe
, Tatsunori Shimoi
, et al.
·
Scientific Reports
·
20
PDF
Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma
2023
·
Ayumi Saito
, Tadaaki Nishikawa
, et al.
·
Gynecologic Oncology
·
19
Intravenous leiomyomatosis treated with radical hysterectomy and adjuvant aromatase inhibitor therapy
2016
·
Chiharu Mizoguchi
, Harunobu Matsumoto
, et al.
·
Journal of obstetrics and gynaecology research
·
19
Changes in HER3 expression profiles between primary and recurrent gynecological cancers
2023
·
Yuki Kojima
, Kazuki Sudo
, et al.
·
Cancer Cell International
·
16
PDF
Recurrent immature teratoma of the ovary with long‐term disease‐free interval
2014
·
Harunobu Matsumoto
, Chiharu Mizoguchi
, et al.
·
Journal of obstetrics and gynaecology research
·
11
Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia
2023
·
Hitomi Sumiyoshi Okuma
, Hiroshi Yoshida
, et al.
·
Cancer Science
·
9
PDF
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma
2024
·
Chiharu Mizoguchi
, Tadaaki Nishikawa
, et al.
·
Journal of Gynecologic Oncology
·
8
PDF
Expression of angiogenic factors in sclerosing stromal tumours of the ovary
2018
·
Tomoko Hirakawa
, Yasushi Kawano
, et al.
·
Journal of Obstetrics and Gynaecology
·
7
Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis
2024
·
Toru Imai
, Yuki Kojima
, et al.
·
Anticancer Research
·
5
PDF
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study
2022
·
Shigemasa Takamizawa
, Tatsunori Shimoi
, et al.
·
BMC Cancer
·
5
PDF
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan‐Asian Study
2025
·
Yuta Maruki
, Yasushi Yatabe
, et al.
·
Hepatology Research
·
4
PDF
Discordances in expression of human epidermal growth factor receptor 2 between primary and metastatic uterine carcinosarcoma: A proposal for HER2-targeted therapy specimen selection
2023
·
Hiroshi Yoshida
, Chiharu Mizoguchi
, et al.
·
Annals of Diagnostic Pathology
·
4
Different interventions for OHVIRA/Herlyn-Werner-Wunderlich syndrome based on age and symptoms: a single-institution cohort study
2025
·
Tomoko Oishi
, Kota Konishi
, et al.
·
BMC Women s Health
·
3
PDF
Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression
2023
·
Rui Kitadai
, Tadaaki Nishikawa
, et al.
·
Journal of Gynecologic Oncology
·
3
PDF
Collision tumour of endometrial stromal sarcoma, uterine tumour resembling ovarian sex-cord tumour, and leiomyoma
2020
·
Chiharu Mizoguchi
, Harunobu Matsumoto
, et al.
·
European Journal of Gynaecological Oncology
·
2
Clinical landscape of precision oncology for rare cancers among diverse Asian populations: Insights from the MASTER KEY registry.
2024
·
Chiharu Mizoguchi
, Hitomi Sumiyoshi Okuma
, et al.
·
Journal of Clinical Oncology
·
1
A case of primary small cell neuroendocrine carcinoma of the uterus
2022
·
Taku Miyanaga
, Kohei Tokuyama
, et al.
·
Radiology Case Reports
·
1
PDF
Folate receptor alpha expression is widely observed in uterine and ovarian carcinosarcoma (209)
2022
·
Ayumi Saito
, Tadaaki Nishikawa
, et al.
·
Gynecologic Oncology
·
1
Molecular classification of biliary tract cancer by RNA clustering analysis and its clinicopathological characteristics.
2026
·
Yuta Maruki
, Kathleen Yasmin de Almeida
, et al.
·
Journal of Clinical Oncology
Perfume trial: Phase II trial of binimetinib in patients with BRAF fusion-positive low-grade glioma or pancreatic cancer.
2025
·
Tomoyuki Satake
, Makoto Ohno
, et al.
·
Journal of Clinical Oncology
Tissue Factor Expression In Gynecologic Carcinosarcoma: Prognostic Significance And Association With HER2 Expression
2025
·
Taro Yamanaka
, Hiroshi Yoshida
, et al.
·
International Journal of Gynecological Cancer
149P Positivity rates of FGFR2 fusion gene or rearrangement and genetic profiling in Asian Cholangiocarcinoma
2024
·
Y. Maruki
, Y. Yatabe
, et al.
·
Annals of Oncology
320 Clinical significance of mesothelin expression and its correlation with HER2 in gynecologic carcinosarcoma
2024
·
Rui Kitadai
, Tadaaki Nishikawa
, et al.
·
International Journal of Gynecological Cancer
An Asian multi-regional registry study of rare cancers: The MASTER KEY ASIA and MASTER KEY Japan projects.
2023
·
Hitomi Sumiyoshi Okuma
, Kan Yonemori
, et al.
·
Journal of Clinical Oncology
MO17-1 Clinical practice of comprehensive genomic profiling in gynecologic malignancies at National Cancer Center Hospital
2022
·
Yohei Chiba
, Kazuki Sudo
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
37
Citation count:
138
H-index:
7
I10-index:
5
Year
Topic
Type